Incubation of sortilin-expressing, PGRN-secreting human glioblastoma U-251 cells with A3-PGRNC15* increased the extracellular PGRN levels to the same extent as latozinemab, with an EC50 value in the same concentration range. Here, SORT1 is linked to glioblastoma.